CD44 is associated with proliferation, rather than a specific cancer stem cell population, in cultured canine cancer cells

Veterinary Immunology and Immunopathology

Volumn 141, Issue 1-2, 2011, Pages 46-57

  Blacking, T M ^a   Waterfall, M ^b   Argyle, D J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Cancer stem cell; Canine; CD44; Flow cytometry

Indexed keywords

DOXORUBICIN; HERMES ANTIGEN;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER STEM CELL; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; DOG; DRUG SENSITIVITY; FLOW CYTOMETRY; NONHUMAN;

ANIMALS; ANTIBODIES, NEOPLASM; ANTIGENS, CD44; ANTIGENS, SURFACE; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; DOG DISEASES; DOGS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; NEOPLASMS; TUMOR STEM CELL ASSAY;

EID: 79953326518     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2011.02.004     Document Type: Article

References (46)

1. Abbasi A.M., Chester K.A., Talbot I.C., Macpherson A.S., Boxer G., Forbes A., Malcolm A.D., Begent R.H. CD44 is associated with proliferation in normal and neoplastic human colorectal epithelial cells. Eur. J. Cancer 1993, 29A:1995-2002.
2. Akhtar N., Padilla M.L., Dickerson E.B., Steinberg H., Breen M., Auerbach R., Helfand S.C. Interleukin-12 inhibits tumor growth in a novel angiogenesis canine hemangiosarcoma xenograft model. Neoplasia 2004, 6:106-116.
3. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:3983-3988.
4. Alho A.M., Underhill C.B. The hyaluronate receptor is preferentially expressed on proliferating epithelial cells. J. Cell Biol. 1989, 108:1557-1565.
5. Bonnet D., Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 1997, 3:730-737.
6. Brock A., Chang H., Huang S. Non-genetic heterogeneity - a mutation-independent driving force for the somatic evolution of tumours. Nat. Rev. 2009, 10:336-342.
7. Chen Y.C., Hsu H.S., Chen Y.W., Tsai T.H., How C.K., Wang C.Y., Hung S.C., Chang Y.L., Tsai M.L., Lee Y.Y., Ku H.H., Chiou S.H. Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells. PloS One 2008, 3:e2637.
8. Chiou S.H., Yu C.C., Huang C.Y., Lin S.C., Liu C.J., Tsai T.H., Chou S.H., Chien C.S., Ku H.H., Lo J.F. Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin. Cancer Res. 2008, 14:4085-4095.
9. Cocola C., Anastasi P., Astigiano S., Piscitelli E., Pelucchi P., Vilardo L., Bertoli G., Beccaglia M., Veronesi M.C., Sanzone S., Barbieri O., Reinbold R.A., Luvoni G.C., Zucchi I. Isolation of canine mammary cells with stem cell properties and tumour-initiating potential. Reproduction in domestic animals. Zuchthygiene 2009, 44(Suppl. 2):214-217.
10. Collins A.T., Berry P.A., Hyde C., Stower M.J., Maitland N.J. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 2005, 65:10946-10951.
11. Dalerba P., Dylla S.J., Park I.K., Liu R., Wang X., Cho R.W., Hoey T., Gurney A., Huang E.H., Simeone D.M., Shelton A.A., Parmiani G., Castelli C., Clarke M.F. Phenotypic characterization of human colorectal cancer stem cells. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:10158-10163.
12. Durand R.E., Olive P.L. Resistance of tumor cells to chemo- and radiotherapy modulated by the three-dimensional architecture of solid tumors and spheroids. Methods Cell Biol. 2001, 64:211-233.
13. East J.A., Hart I.R. CD44 and its role in tumour progression and metastasis. Eur. J. Cancer 1993, 29A:1921-1922.
14. Else R.W., Norval M., Neill W.A. The characteristics of a canine mammary carcinoma cell line, REM 134. Br. J. Cancer 1982, 46:675-681.
15. Fillmore C.M., Kuperwasser C. Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy. Breast Cancer Res. 2008, 10:R25.
16. Furuta K., Zahurak M., Yang X.L., Rosada C., Goodman S.N., August J.T., Hamilton S.R. Relationship between CD44 expression and cell proliferation in epithelium and stroma of colorectal neoplasms. Am. J. Pathol. 1996, 149:1147-1155.
17. Goodison S., Urquidi V., Tarin D. CD44 cell adhesion molecules. Mol. Pathol. 1999, 52:189-196.
18. Gupta P.B., Chaffer C.L., Weinberg R.A. Cancer stem cells: mirage or reality?. Nat. Med. 2009, 15:1010-1012.
19. Guzman M.L., Rossi R.M., Neelakantan S., Li X., Corbett C.A., Hassane D.C., Becker M.W., Bennett J.M., Sullivan E., Lachowicz J.L., Vaughan A., Sweeney C.J., Matthews W., Carroll M., Liesveld J.L., Crooks P.A., Jordan C.T. An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells. Blood 2007, 110:4427-4435.
20. Harper L.J., Costea D.E., Gammon L., Fazil B., Biddle A., Mackenzie I.C. Normal and malignant epithelial cells with stem-like properties have an extended G2 cell cycle phase that is associated with apoptotic resistance. BMC Cancer 2010, 10:166.
21. Herrera-Gayol A., Jothy S. CD44 modulates Hs578T human breast cancer cell adhesion, migration, and invasiveness. Exp. Mol. Pathol. 1999, 66:99-108.
22. Hong D., Gupta R., Ancliff P., Atzberger A., Brown J., Soneji S., Green J., Colman S., Piacibello W., Buckle V., Tsuzuki S., Greaves M., Enver T. Initiating and cancer-propagating cells in TEL-AML1-associated childhood leukemia. Science 2008, 319:336-339.
23. Hurt E.M., Kawasaki B.T., Klarmann G.J., Thomas S.B., Farrar W.L. CD44+ CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis. Br. J. Cancer 2008, 98:756-765.
24. Jamieson C.H., Ailles L.E., Dylla S.J., Muijtjens M., Jones C., Zehnder J.L., Gotlib J., Li K., Manz M.G., Keating A., Sawyers C.L., Weissman I.L. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. New Engl. J. Med. 2004, 351:657-667.
25. Kelly P.N., Dakic A., Adams J.M., Nutt S.L., Strasser A. Tumor growth need not be driven by rare cancer stem cells. Science 2007, 317:337.
26. Li C., Heidt D.G., Dalerba P., Burant C.F., Zhang L., Adsay V., Wicha M., Clarke M.F., Simeone D.M. Identification of pancreatic cancer stem cells. Cancer Res. 2007, 67:1030-1037.
27. Madrazo J., Garcia-Fernandez R.A., Garcia-Iglesias M.J., Duran A.J., Espinosa J., Perez-Martinez C. The role of CD44 adhesion factor in canine mammary carcinomas. Vet. J. 2009, 180:371-376.
28. Marhaba R., Zoller M. CD44 in cancer progression: adhesion, migration and growth regulation. J. Mol. Histol. 2004, 35:211-231.
29. Neame S.J., Isacke C.M. The cytoplasmic tail of CD44 is required for basolateral localization in epithelial MDCK cells but does not mediate association with the detergent-insoluble cytoskeleton of fibroblasts. J. Cell Biol. 1993, 121:1299-1310.
30. Nowell P.C. The clonal evolution of tumor cell populations. Science 1976, 194:23-28.
31. Paltian V., Alldinger S., Baumgartner W., Wohlsein P. Expression of CD44 in canine mammary tumours. J. Comp. Pathol. 2009, 141:237-247.
32. Prince M.E., Sivanandan R., Kaczorowski A., Wolf G.T., Kaplan M.J., Dalerba P., Weissman I.L., Clarke M.F., Ailles L.E. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:973-978.
33. Quintana E., Shackleton M., Sabel M.S., Fullen D.R., Johnson T.M., Morrison S.J. Efficient tumour formation by single human melanoma cells. Nature 2008, 456:593-598.
34. Reya T., Morrison S.J., Clarke M.F., Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature 2001, 414:105-111.
35. Reynolds B.A., Weiss S. Clonal and population analyses demonstrate that an EGF-responsive mammalian embryonic CNS precursor is a stem cell. Dev. Biol. 1996, 175:1-13.
36. Shackleton M., Quintana E., Fearon E.R., Morrison S.J. Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell 2009, 138:822-829.
37. Shipitsin M., Polyak K. The cancer stem cell hypothesis: in search of definitions, markers, and relevance. Lab. Invest. 2008, 88:459-463.
38. Singec I., Knoth R., Meyer R.P., Maciaczyk J., Volk B., Nikkhah G., Frotscher M., Snyder E.Y. Defining the actual sensitivity and specificity of the neurosphere assay in stem cell biology. Nat. Methods 2006, 3:801-806.
39. Sneath R.J., Mangham D.C. The normal structure and function of CD44 and its role in neoplasia. Mol. Pathol. 1998, 51:191-200.
40. Stoica G., Lungu G., Martini-Stoica H., Waghela S., Levine J., Smith R. Identification of cancer stem cells in dog glioblastoma. Vet. Pathol. 2009, 46:391-406.
41. Strandstrom H.V., Rimaila-Parnanen E. Canine atypical malignant lymphoma. Am. J. Vet. Res. 1979, 40:1033-1034.
42. Takaishi S., Okumura T., Tu S., Wang S.S., Shibata W., Vigneshwaran R., Gordon S.A., Shimada Y., Wang T.C. Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells 2009, 27:1006-1020.
43. Tirino V., Desiderio V., d'Aquino R., De Francesco F., Pirozzi G., Graziano A., Galderisi U., Cavaliere C., De Rosa A., Papaccio G., Giordano A. Detection and characterization of CD133+ cancer stem cells in human solid tumours. PloS One 2008, 3:e3469.
44. Visvader J.E., Lindeman G.J. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat. Rev. Cancer 2008, 8:755-768.
45. Wilson H., Huelsmeyer M., Chun R., Young K.M., Friedrichs K., Argyle D.J. Isolation and characterisation of cancer stem cells from canine osteosarcoma. Vet. J. 2008, 175:69-75.
46. Zheng X., Shen G., Yang X., Liu W. Most c6 cells are cancer stem cells: evidence from clonal and population analyses. Cancer Res. 2007, 67:3691-3697.